NEW YORK, June 21 (GenomeWeb News) - Interleukin Genetics has licensed an algorithm from GeneOb to develop a genetic weight management test, Interleukin said today.
GeneOb's technology uses specific genetic markers to determine risk of individual weight gain and response to weight-loss programs.
Interleukin Genetics intends to release its genetic weight management test next year through its commercialization partner, Alticor.
Under the licensing agreement, Interleukin Genetics has the exclusive right to market the genetic test based on GeneOb's algorithm in North America through multi-level marketing channels.
The companies also agreed to negotiate a pre-determined period license for additional products, undisclosed at this time, that use GeneOb's technology and Interleukin Genetics' expertise.
Financial terms of the agreement were not disclosed.